TY - JOUR
T1 - Long runs of homozygosity are associated with Alzheimer's disease
AU - Moreno-Grau, Sonia
AU - Fernández, Maria Victoria
AU - De Rojas, Itziar
AU - García-González, Pablo
AU - Hernández, Isabel
AU - Farias, Fabiana
AU - Budde, John P.
AU - Quintela, Inés
AU - Madrid, Laura
AU - González-Pérez, Antonio
AU - Montrreal, Laura
AU - Alarcón-Martín, Emilio
AU - Alegret, Montserrat
AU - Maroñas, Olalla
AU - Pineda, Juan Antonio
AU - Macías, Juan
AU - Marquié, Marta
AU - Valero, Sergi
AU - Benaque, Alba
AU - Clarimón, Jordi
AU - Bullido, María J.
AU - García-Ribas, Guillermo
AU - Pastor, Pau
AU - Sánchez-Juan, Pascual
AU - Alvarez, Victoria
AU - Piñol-Ripoll, Gerard
AU - García-Alberca, Jose María
AU - Royo, José Luis
AU - Franco-Macías, Emilio
AU - Mir, Pablo
AU - Calero, Miguel
AU - Medina, Miguel
AU - Rábano, Alberto
AU - Ávila, Jesús
AU - Antúnez, Carmen
AU - Real, Luis M.
AU - Orellana, Adelina
AU - Carracedo, Ángel
AU - Sáez, María Eugenia
AU - Tárraga, Lluís
AU - Boada, Mercè
AU - Cruchaga, Carlos
AU - Ruiz, Agustín
PY - 2021
Y1 - 2021
N2 - Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [ β (CI 95%) = 0.070 (0.037-0.104); P = 3.91 × 10 −5 ; β (CI95%) = 0.043 (0.009-0.076); P = 0.013]. ROHs increasing the risk of AD (OR > 1) were significantly overrepresented compared to ROHs increasing protection (p < 2.20 × 10 −16). A significant ROH association with AD risk was detected upstream the HS3ST1 locus (chr4:11,189,482‒11,305,456), (β (CI 95%) = 1.09 (0.48 ‒ 1.48), p value = 9.03 × 10 −4), previously related to AD. Next, to search for recessive candidate variants in ROHs, we constructed a homozygosity map of inbred AD cases extracted from an outbred population and explored ROH regions in whole-exome sequencing data (N = 1449). We detected a candidate marker, rs117458494, mapped in the SPON1 locus, which has been previously associated with amyloid metabolism. Here, we provide a research framework to look for recessive variants in AD using outbred populations. Our results showed that AD cases have enriched homozygosity, suggesting that recessive effects may explain a proportion of AD heritability.
AB - Long runs of homozygosity (ROH) are contiguous stretches of homozygous genotypes, which are a footprint of inbreeding and recessive inheritance. The presence of recessive loci is suggested for Alzheimer's disease (AD); however, their search has been poorly assessed to date. To investigate homozygosity in AD, here we performed a fine-scale ROH analysis using 10 independent cohorts of European ancestry (11,919 AD cases and 9181 controls.) We detected an increase of homozygosity in AD cases compared to controls [ β (CI 95%) = 0.070 (0.037-0.104); P = 3.91 × 10 −5 ; β (CI95%) = 0.043 (0.009-0.076); P = 0.013]. ROHs increasing the risk of AD (OR > 1) were significantly overrepresented compared to ROHs increasing protection (p < 2.20 × 10 −16). A significant ROH association with AD risk was detected upstream the HS3ST1 locus (chr4:11,189,482‒11,305,456), (β (CI 95%) = 1.09 (0.48 ‒ 1.48), p value = 9.03 × 10 −4), previously related to AD. Next, to search for recessive candidate variants in ROHs, we constructed a homozygosity map of inbred AD cases extracted from an outbred population and explored ROH regions in whole-exome sequencing data (N = 1449). We detected a candidate marker, rs117458494, mapped in the SPON1 locus, which has been previously associated with amyloid metabolism. Here, we provide a research framework to look for recessive variants in AD using outbred populations. Our results showed that AD cases have enriched homozygosity, suggesting that recessive effects may explain a proportion of AD heritability.
KW - Genomics
KW - Psychiatric disorders
U2 - 10.1038/s41398-020-01145-1
DO - 10.1038/s41398-020-01145-1
M3 - Article
C2 - 33627629
SN - 2158-3188
VL - 11
JO - Translational Psychiatry
JF - Translational Psychiatry
ER -